Kapitza, Christoph, et al
The platform differentiates itself through its integrated care model
Start your intake What Clinical Trials Reveal About GLP-1 and Weight Loss Without Exercise Landmark trials including STEP 1, STEP 2, and STEP 3 (semaglutide) and SURMOUNT 1-4 (tirzepatide) enrolled participants across varying activity levels
Identification and validation of amino acid-based mild exfoliating agents through a de novo screening method
Serious side effects may include pancreatitis, gallstones, low blood sugar (hypoglycemia), kidney problems including kidney failure, changes in vision in people with type 2 diabetes, increased resting heart rate, depression or thoughts of suicide